Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Oncology: early-phase trial registry
15 of 25 indexed Oncology trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #652 of 28,707 conditions by registered trial count.
25 US clinical trials · 15 currently recruiting · #652 of 28,707 conditions by registered trial count
Oncology: 25 US clinical trials tracked, 15 recruiting.
Oncology is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Amgen, running 2 of these trials.
Enrollment posture brief
Registry condition oncology
OPEN 15 | RECR 60% | LATE 1 | EARLY 9 | RANK #652 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)
Oncology lists 15 open slots (60% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Oncology on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Oncology is recruiting above its size-band peers.
15 of 25 indexed trials (60%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Oncology trials is spread across many organizations.
Amgen accounts for 2 of 25 trials (8%). 23 distinct sponsors appear on at least one study for this condition label.
-
Typical Oncology enrolment sits around 94 participants.
Median target enrolment is 94 among the 25 trials that report a genuine target (sentinel values excluded). 13 of those (52%) plan for fewer than 100 participants.
-
Oncology research is mostly interventional.
21 interventional and 4 observational studies make up this index (84% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
25 total, page 1 of 1
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
UMC Utrecht
NCT04075305
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
University of Rochester
NCT06697600
Autoimmunity After Checkpoint Blockade
Abramson Cancer Center at Penn Medicine
NCT04119713
AIMS Cancer Outcomes Study
Advanced Integrative Medical Science Institute
NCT04495790
xPedite: A Study to Expedite DIPG and DMG Research
xCures
NCT06140719
A Study in Patients With Advanced Cancers
BiOneCure Therapeutics
NCT05320588
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
Johns Hopkins All Children's Hospital
NCT06346782
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Nested Therapeutics
NCT06326411
Clinical Alternatives for Reducing Harm Using E-cigarettes
Medical University of South Carolina
NCT07039292
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
The Hospital for Sick Children
NCT03118986
Leading Healthy Eating and Activity Promotion Program
University of Alabama at Birmingham
NCT06868524
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Trethera
NCT05055609
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
University of Florida
NCT04281017
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
University of Alabama at Birmingham
NCT07281287
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
University of Hawaii
NCT06237816
Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer
Stanford University
NCT06824441
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation
Baptist Health South Florida
NCT04375891
AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR
Amgen
NCT00770536
The STEPP Study: Sensors To Evaluate Physical Performance
UNC Lineberger Comprehensive Cancer Center
NCT03952767
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Amgen
NCT00413283
Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function
Gilead Sciences
NCT02521376
Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer
Dana-Farber Cancer Institute
NCT03709225
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
Kartos Therapeutics
NCT02016729
EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
Masonic Cancer Center, University of Minnesota
NCT05809557
A Study of AMG 820 in Subjects With Advanced Solid Tumors
AmMax Bio
NCT01444404
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Oncology records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Oncology trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Oncology page
25 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 Oncology trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Amgen sponsors the most Oncology trials on record, review their full trial history before evaluating a specific study. See Amgen's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Oncology condition card totals 25 registered trials; most-linked intervention AMG 232; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.